BR112013018679A2 - agente para o tratamento da alopecia - Google Patents
agente para o tratamento da alopeciaInfo
- Publication number
- BR112013018679A2 BR112013018679A2 BR112013018679A BR112013018679A BR112013018679A2 BR 112013018679 A2 BR112013018679 A2 BR 112013018679A2 BR 112013018679 A BR112013018679 A BR 112013018679A BR 112013018679 A BR112013018679 A BR 112013018679A BR 112013018679 A2 BR112013018679 A2 BR 112013018679A2
- Authority
- BR
- Brazil
- Prior art keywords
- agent
- treating alopecia
- alopecia
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011-011437 | 2011-01-21 | ||
JP2011011437 | 2011-01-21 | ||
PCT/JP2012/051272 WO2012099258A1 (ja) | 2011-01-21 | 2012-01-20 | 脱毛症治療剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112013018679A2 true BR112013018679A2 (pt) | 2016-10-18 |
BR112013018679B1 BR112013018679B1 (pt) | 2022-04-12 |
Family
ID=46515875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013018679-8A BR112013018679B1 (pt) | 2011-01-21 | 2012-01-20 | Agente para o tratamento da alopecia e uso de um peptídeo natriurético do tipo c |
Country Status (14)
Country | Link |
---|---|
US (4) | US20120238498A1 (pt) |
EP (2) | EP2666475B1 (pt) |
JP (1) | JP5261620B2 (pt) |
KR (1) | KR101954869B1 (pt) |
CN (2) | CN103547282A (pt) |
AU (2) | AU2012207816B2 (pt) |
BR (1) | BR112013018679B1 (pt) |
CA (1) | CA2825382C (pt) |
DK (1) | DK2666475T3 (pt) |
ES (1) | ES2647680T3 (pt) |
HU (1) | HUE035584T2 (pt) |
MX (1) | MX353295B (pt) |
TW (2) | TW201811360A (pt) |
WO (1) | WO2012099258A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101226165B1 (ko) | 2009-07-23 | 2013-01-24 | 가부시키가이샤 이기스 | 피부 외용제 조성물 |
MX353295B (es) | 2011-01-21 | 2018-01-08 | Endo Kyoko | Agente para el tratamiento de la alopecia. |
WO2016175559A2 (ko) * | 2015-04-28 | 2016-11-03 | (주) 메드빌 | 지모와 두릅의 복합 추출물을 함유하는 탈모 방지 및 발모 개선용 조성물 |
WO2016194855A1 (ja) * | 2015-05-29 | 2016-12-08 | 株式会社イギス | 環状ペプチド並びに該環状ペプチドを含む医薬、外用剤および化粧料 |
EP3330280A4 (en) * | 2015-07-31 | 2019-06-12 | Igisu Co., Ltd. | CYCLIC PEPTIDE CNP AND MEDICINE, PREPARATION FOR EXTERNAL USE AND COSMETIC PRODUCT, CONTAINING ALL OF SAID CYCLIC PEPTIDE |
US20170135969A1 (en) | 2015-11-12 | 2017-05-18 | Jds Therapeutics, Llc | Topical arginine-silicate-inositol for wound healing |
CN105617360B (zh) * | 2015-12-04 | 2018-12-21 | 中国农业大学 | C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用 |
BR112018068886A2 (pt) * | 2016-03-18 | 2019-01-22 | Caregen Co Ltd | conjugado de finasterida com peptídeo |
CA3018561A1 (en) * | 2016-03-21 | 2017-09-28 | Rhode Island Council On Postsecondary Education | Ph-sensitive peptides |
US11312758B2 (en) | 2016-08-18 | 2022-04-26 | National University Of Singapore | Peptides with vasodilatory and/or diuretic functions |
KR101948238B1 (ko) * | 2016-08-19 | 2019-02-14 | (주)케어젠 | 미녹시딜과 펩타이드의 결합체 |
WO2018045244A1 (en) * | 2016-09-01 | 2018-03-08 | Jds Therapeutics, Llc | Magnesium biotinate compositions and methods of use |
US9956158B2 (en) * | 2016-09-08 | 2018-05-01 | Synergistic Therapeutics, Llc | Topical hair growth formulation |
CN108424446A (zh) * | 2017-02-13 | 2018-08-21 | 成都贝爱特生物科技有限公司 | 新的重组人心房利钠肽突变体的制备及其应用 |
EP3760214A4 (en) * | 2018-02-28 | 2021-11-17 | Mother"S Pharmaceutical Co.,Ltd. | COMPOSITION TO PREVENT HAIR LOSS OR STIMULATE HAIR GROWTH |
CN109011138A (zh) * | 2018-05-07 | 2018-12-18 | 北京全贵医疗科技有限公司 | 基于头部图像的头部理疗方法及装置 |
WO2020123312A1 (en) | 2018-12-09 | 2020-06-18 | Weinberg Assa | Method to prevent and treat macular degeneration by vasodilators |
WO2020154304A1 (en) * | 2019-01-24 | 2020-07-30 | Weinberg Assa | Method to prevent and treat alopecia by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers |
TW202419463A (zh) | 2022-11-02 | 2024-05-16 | 丹麥商諾佛 儂迪克股份有限公司 | Cnp化合物 |
KR102677730B1 (ko) * | 2023-03-27 | 2024-06-27 | 나인바이오팜 주식회사 | 지방 분해 효능을 갖는 펩타이드 및 이의 용도 |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4804650A (en) | 1986-10-28 | 1989-02-14 | Biotechnology Research Associates, J.V. | Analogs of atrial natriuretic peptides |
US5047397A (en) | 1988-08-26 | 1991-09-10 | California Biotechnology Inc. | Linear analogs of atrial natriuretic peptides |
US5114923A (en) | 1988-05-31 | 1992-05-19 | California Biotechnology Inc. | Recombinant techniques for production of novel natriuretic and vasodilator peptides |
US5204328A (en) | 1990-06-26 | 1993-04-20 | Merck & Co., Inc. | Peptides having atrial natriuretic factor activity |
JP2809533B2 (ja) * | 1991-01-31 | 1998-10-08 | 壽之 松尾 | Cnp類似体ペプチド |
JPH05207891A (ja) | 1991-03-08 | 1993-08-20 | Shionogi & Co Ltd | 脳性ナトリウム利尿ペプチドの製造方法 |
WO1994020534A1 (en) | 1993-03-03 | 1994-09-15 | Mayo Foundation For Medical Education And Research | Vasonatrin peptide and analogs thereof |
TW382595B (en) * | 1993-10-15 | 2000-02-21 | Merck & Co Inc | Pharmaceutical composition for use in arresting and reversing androgenic alopecia |
US6028055A (en) | 1996-10-22 | 2000-02-22 | Genetech, Inc. | Receptor selective BNP |
US5965533A (en) | 1997-05-23 | 1999-10-12 | Baxter International Inc. | Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions |
JP3799465B2 (ja) | 1998-09-28 | 2006-07-19 | 参天製薬株式会社 | ナトリウム利尿ペプチドを有効成分とする涙液分泌促進または角結膜障害治療用点眼剤 |
US6407211B1 (en) | 1999-12-17 | 2002-06-18 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides |
IL142118A0 (en) * | 2001-03-20 | 2002-03-10 | Prochon Biotech Ltd | Method and composition for treatment of skeletal dysplasias |
US7655772B2 (en) | 2002-09-06 | 2010-02-02 | University Of South Florida | Materials and methods for treatment of allergic diseases |
US20050271596A1 (en) * | 2002-10-25 | 2005-12-08 | Foamix Ltd. | Vasoactive kit and composition and uses thereof |
US7887842B2 (en) * | 2003-02-07 | 2011-02-15 | Teikoku Pharma Usa, Inc. | Methods of administering a dermatological agent to a subject |
US20070270337A1 (en) | 2003-06-13 | 2007-11-22 | Daiichi Asubio Pharma Co., Ltd. | Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases |
KR100509446B1 (ko) | 2003-06-19 | 2005-08-22 | 세메스 주식회사 | 반도체 제조 공정에서 사용되는 약액 공급 장치 |
CN101208353B (zh) | 2003-06-20 | 2011-12-14 | 梅约医学教育与研究基金会 | 脑利尿钠肽的同种型 |
GB2403533A (en) * | 2003-06-30 | 2005-01-05 | Orion Corp | Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof |
EP1730181A2 (en) | 2004-01-27 | 2006-12-13 | Compugen USA, Inc. | Novel brain natriuretic peptide variants and methods of use thereof |
JP2007525213A (ja) | 2004-01-27 | 2007-09-06 | コンピュゲン ユーエスエイ,インク. | 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法 |
CA2561530C (en) | 2004-03-31 | 2014-04-22 | Kazuwa Nakao | Therapeutic or prophylactic agent for arthritis |
CN1960757A (zh) | 2004-03-31 | 2007-05-09 | 中尾一和 | 身高增加用组合物 |
CA2576852A1 (en) | 2004-08-11 | 2006-02-23 | Alza Corporation | Apparatus and method for transdermal delivery of natriuretic peptides |
EP1810716A1 (de) | 2005-12-23 | 2007-07-25 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Verfahren zur Bräunung der Haut |
US7196223B2 (en) | 2005-05-03 | 2007-03-27 | Solutia, Inc. | Higher alcohols for solvents in amine production |
JP3830960B1 (ja) * | 2005-08-12 | 2006-10-11 | 建仁 河乃 | 育毛物質 |
BRPI0716416A2 (pt) | 2006-08-08 | 2016-10-11 | Mayo Foundation | polipeptídeo substancialmente puro entre 37 e 47 besíduos de aminoácido de comprimento, ácido nucléico isolado, vetor: célula hospedeira e composição farmacêutica |
JPWO2008032450A1 (ja) | 2006-09-15 | 2010-01-21 | 国立大学法人京都大学 | 脂肪肝の予防剤および/または治療剤 |
KR100842392B1 (ko) | 2006-10-10 | 2008-07-01 | 주식회사 일진글로벌 | 토크를 측정할 수 있는 구동휠시스템 |
JP2008140125A (ja) | 2006-12-01 | 2008-06-19 | Rakuten Inc | サービス予約システム、予約登録装置、参加者募集方法及び参加者募集処理プログラム |
US20120034183A1 (en) | 2006-12-19 | 2012-02-09 | Michael Cohen | Compositions and methods for growing embryonic stem cells |
JP5010913B2 (ja) * | 2006-12-31 | 2012-08-29 | 寿子 小出 | 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法 |
JP2010168283A (ja) | 2007-04-24 | 2010-08-05 | Yamaguchi Univ | ナトリウム利尿ペプチドを有効成分とする肝硬変・前癌病変の抑制剤 |
JP5207316B2 (ja) | 2007-05-10 | 2013-06-12 | 国立大学法人名古屋大学 | 腹膜線維化抑制用医薬組成物 |
JP2009013122A (ja) * | 2007-07-06 | 2009-01-22 | Masaru Okura | 育毛剤 |
WO2009046865A2 (en) | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Cholecystokinin-33 alone or in combination with trap-14 as therapeutic agent |
EP2187953A2 (en) | 2007-09-11 | 2010-05-26 | Mondobiotech Laboratories AG | Use of a peptide as a therapeutic agent |
AU2008326327A1 (en) | 2007-11-21 | 2009-05-28 | Biomarin Pharmaceutical Inc. | Variants of C-type natriuretic peptide |
US8455438B2 (en) * | 2008-12-29 | 2013-06-04 | Mayo Foundation For Medical Education And Research | Natriuretic polypeptides for reducing or preventing restenosis |
US20110014180A1 (en) * | 2009-07-16 | 2011-01-20 | Masafumi Koide | Preparations for tissue restoration containing atrial diuretic hormone and family molecules as active ingredients; method of restoring tissue using the preparation; agents for growing, restoring, promoting growth of hair and agents for promoting restoration of skin tissue and cardiac muscle tissue containing atrial diuretic hormone family molecules as active ingredients; method of growing, restoring, promoting growth of hair by using the agents; and method of promoting restoration of skin tissue and cardiac muscle tissue |
KR101226165B1 (ko) * | 2009-07-23 | 2013-01-24 | 가부시키가이샤 이기스 | 피부 외용제 조성물 |
KR101229546B1 (ko) * | 2009-08-27 | 2013-02-05 | 쿄고 엔도 | 비염 치료제 |
MX353295B (es) | 2011-01-21 | 2018-01-08 | Endo Kyoko | Agente para el tratamiento de la alopecia. |
-
2012
- 2012-01-20 MX MX2013008422A patent/MX353295B/es active IP Right Grant
- 2012-01-20 BR BR112013018679-8A patent/BR112013018679B1/pt active IP Right Grant
- 2012-01-20 CN CN201280013887.7A patent/CN103547282A/zh active Pending
- 2012-01-20 CN CN201910952287.0A patent/CN110801514A/zh active Pending
- 2012-01-20 HU HUE12736336A patent/HUE035584T2/en unknown
- 2012-01-20 EP EP12736336.4A patent/EP2666475B1/en active Active
- 2012-01-20 ES ES12736336.4T patent/ES2647680T3/es active Active
- 2012-01-20 EP EP17184915.1A patent/EP3269382A1/en not_active Withdrawn
- 2012-01-20 DK DK12736336.4T patent/DK2666475T3/da active
- 2012-01-20 WO PCT/JP2012/051272 patent/WO2012099258A1/ja active Application Filing
- 2012-01-20 CA CA2825382A patent/CA2825382C/en active Active
- 2012-01-20 KR KR1020137021710A patent/KR101954869B1/ko active IP Right Grant
- 2012-01-20 AU AU2012207816A patent/AU2012207816B2/en active Active
- 2012-01-20 JP JP2012549041A patent/JP5261620B2/ja not_active Expired - Fee Related
- 2012-01-21 US US13/355,484 patent/US20120238498A1/en not_active Abandoned
- 2012-01-30 TW TW106138356A patent/TW201811360A/zh unknown
- 2012-01-30 TW TW101102860A patent/TWI619505B/zh active
-
2014
- 2014-04-17 US US14/254,938 patent/US9480728B2/en active Active
-
2016
- 2016-09-20 US US15/270,350 patent/US9808511B2/en active Active
-
2017
- 2017-06-05 AU AU2017203793A patent/AU2017203793A1/en not_active Abandoned
- 2017-10-06 US US15/726,519 patent/US11571464B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013018679A2 (pt) | agente para o tratamento da alopecia | |
BR112014032105A2 (pt) | método para o tratamento de câncer | |
BR112014009528A2 (pt) | métodos e composições para tratar eritropoiese ineficaz | |
BR112013019732A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
CR20140119A (es) | Composición y apósito para tratamiento de heridas | |
BR112014013246A8 (pt) | composição catalisadora, e, método para tratar nox | |
BR112013007678A2 (pt) | método para tratamento de doenças alérgicas | |
DK2707030T3 (da) | Cancerbehandlinger | |
CO6890100A2 (es) | Tratamientos de combinación para hepatitis c | |
BR112013016491A2 (pt) | método para tratamento de têxtil | |
BR112015028115A2 (pt) | métodos e composições para o tratamento de câncer | |
BR112014032053A2 (pt) | composto, composição farmacêutica, utilização de um composto, método para o tratamento de câncer e invenção | |
BR112014031896A2 (pt) | composto, composição farmacêutica, e, método para o tratamento de um distúrbio | |
BR112015011262A2 (pt) | artigo absorvente e método para produzir um artigo absorvente | |
BR112014022694A2 (pt) | novos métodos e composições para o tratamento de doença | |
BR112014031512A2 (pt) | composição cosmética e método para o tratamento cosmético. | |
BR112015006512A2 (pt) | composição para tratar tecidos biológicos danificados | |
BR112014004414A2 (pt) | composições e métodos para tratar doença neurodegenerativa | |
BR112013023142A2 (pt) | método de tratamento de cabelos | |
BR112014031899A8 (pt) | composto, composição farmacêutica, e, método para tratamento de um distúrbio | |
EP2786738A4 (en) | HAIR TREATMENT COMPOSITION | |
BR112014029487A2 (pt) | método para o tratamento cosmético | |
BR112013022306A2 (pt) | método, e, composição | |
BR112014002102A2 (pt) | curativo para ferimentos e métodos para fazer o curativo para ferimentos | |
BR112013028890A2 (pt) | composições e métodos para o tratamento de câncer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/01/2012, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |